Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Hut 8 Corp (HUT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Hut 8 Corp — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Hut 8 Corp trades at $72.25 (market cap $10.31B). The key difference: Hut 8 Corp is the larger of the two by market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Hut 8 Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Hut 8 Corp for 12 Days on average.
| HNGE | HUT | |
|---|---|---|
Market Cap | $8.48B | $10.31B |
Volume | 879,799 | 4,904,746 |
Sector | Health | Financials |
52-Week High | $105.14 | $133.02 |
52-Week Low | $31.17 | $33.76 |
Typical Hold Time | 0 Days | 12 Days |
Enterprise Value | $8.10B | $17.74B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
HUT trades at $83.61, down 1.91% on the day, with a bearish technical signal from moving averages. The company shows strong revenue growth projections but faces significant profitability challenges with a -188.59% net income margin. Recent developments include securing a $1.07 billion credit facility and positive analyst coverage with 94% buy ratings and a $163.62 consensus price target.
While analyst sentiment remains overwhelmingly positive, HUT faces substantial execution risks with consecutive earnings misses and negative cash flow from operations. The stock offers significant upside potential based on analyst targets but requires careful monitoring of profitability improvements and AI infrastructure contract execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Hut 8 Corp
Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.
Read more on HUT →
